Virginie Mariot

1.6k total citations
38 papers, 1.1k citations indexed

About

Virginie Mariot is a scholar working on Molecular Biology, Genetics and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Virginie Mariot has authored 38 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Molecular Biology, 9 papers in Genetics and 7 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Virginie Mariot's work include Muscle Physiology and Disorders (28 papers), Neurogenetic and Muscular Disorders Research (9 papers) and RNA Research and Splicing (7 papers). Virginie Mariot is often cited by papers focused on Muscle Physiology and Disorders (28 papers), Neurogenetic and Muscular Disorders Research (9 papers) and RNA Research and Splicing (7 papers). Virginie Mariot collaborates with scholars based in France, United Kingdom and United States. Virginie Mariot's co-authors include Julie Dumonceaux, Agnès Linglart, Thomas Voit, Francesco Muntoni, Gillian Butler‐Browne, Vincent Mouly, Romain Joubert, Stéphanie Maupetit‐Mehouas, Christophe Hourdé and Christiane Sinding and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Virginie Mariot

37 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Virginie Mariot France 18 866 235 205 154 150 38 1.1k
Virginie Carmignac France 17 714 0.8× 85 0.4× 182 0.9× 101 0.7× 269 1.8× 38 1.1k
Yuko Nitahara‐Kasahara Japan 19 540 0.6× 205 0.9× 206 1.0× 50 0.3× 51 0.3× 35 876
Lori A. Reed United States 7 833 1.0× 73 0.3× 176 0.9× 141 0.9× 107 0.7× 8 1.0k
Sergia Bortolanza Spain 11 547 0.6× 73 0.3× 253 1.2× 113 0.7× 40 0.3× 12 725
David R. Deyle United States 15 477 0.6× 93 0.4× 333 1.6× 53 0.3× 130 0.9× 34 955
Vincent Marion France 22 853 1.0× 88 0.4× 876 4.3× 50 0.3× 89 0.6× 42 1.5k
Siamak Agha‐Mohammadi United States 14 642 0.7× 94 0.4× 248 1.2× 75 0.5× 60 0.4× 18 1.0k
Joel Schneider United States 15 396 0.5× 44 0.2× 124 0.6× 78 0.5× 89 0.6× 47 657
Bernard Gjata France 15 375 0.4× 82 0.3× 330 1.6× 93 0.6× 36 0.2× 26 694
Regan‐Heng Zhang Canada 6 605 0.7× 194 0.8× 55 0.3× 186 1.2× 44 0.3× 6 813

Countries citing papers authored by Virginie Mariot

Since Specialization
Citations

This map shows the geographic impact of Virginie Mariot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Virginie Mariot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Virginie Mariot more than expected).

Fields of papers citing papers by Virginie Mariot

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Virginie Mariot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Virginie Mariot. The network helps show where Virginie Mariot may publish in the future.

Co-authorship network of co-authors of Virginie Mariot

This figure shows the co-authorship network connecting the top 25 collaborators of Virginie Mariot. A scholar is included among the top collaborators of Virginie Mariot based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Virginie Mariot. Virginie Mariot is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mariot, Virginie, et al.. (2024). Impact of Disease Severity and Disease-Modifying Therapies on Myostatin Levels in SMA Patients. International Journal of Molecular Sciences. 25(16). 8763–8763. 3 indexed citations
2.
Mariot, Virginie, Julie Dumonceaux, John R. Counsell, et al.. (2022). Transiently expressed CRISPR/Cas9 induces wild-type dystrophin in vitro in DMD patient myoblasts carrying duplications. Scientific Reports. 12(1). 3756–3756. 5 indexed citations
3.
Mariot, Virginie & Julie Dumonceaux. (2022). Gene Editing to Tackle Facioscapulohumeral Muscular Dystrophy. SHILAP Revista de lepidopterología. 4. 937879–937879. 6 indexed citations
4.
Mariot, Virginie, Romain Joubert, Laura Le Gall, et al.. (2021). RIPK3‐mediated cell death is involved in DUX4‐mediated toxicity in facioscapulohumeral dystrophy. Journal of Cachexia Sarcopenia and Muscle. 12(6). 2079–2090. 11 indexed citations
5.
Gall, Laura Le, et al.. (2020). DUX4 Expression in FSHD Muscles: Focus on Its mRNA Regulation. Journal of Personalized Medicine. 10(3). 73–73. 12 indexed citations
6.
Falzarano, Maria Sofia, Monica Argenziano, Virginie Mariot, et al.. (2020). Chitosan-Shelled Nanobubbles Irreversibly Encapsulate Morpholino Conjugate Antisense Oligonucleotides and Are Ineffective for Phosphorodiamidate Morpholino-Mediated Gene Silencing of DUX4. Nucleic Acid Therapeutics. 31(3). 201–207. 11 indexed citations
7.
Mariot, Virginie, et al.. (2020). A Deoxyribonucleic Acid Decoy Trapping DUX4 for the Treatment of Facioscapulohumeral Muscular Dystrophy. Molecular Therapy — Nucleic Acids. 22. 1191–1199. 10 indexed citations
8.
Gall, Laura Le, et al.. (2020). Therapeutic Strategies Targeting DUX4 in FSHD. Journal of Clinical Medicine. 9(9). 2886–2886. 22 indexed citations
9.
Mariot, Virginie, Romain Joubert, Christophe Hourdé, et al.. (2017). Downregulation of myostatin pathway in neuromuscular diseases may explain challenges of anti-myostatin therapeutic approaches. Nature Communications. 8(1). 1859–1859. 110 indexed citations
10.
Puppo, Francesca, Stéphane Roche, Camille Dion, et al.. (2016). Segregation between SMCHD1 mutation, D4Z4 hypomethylation and Facio-Scapulo-Humeral Dystrophy: a case report. BMC Medical Genetics. 17(1). 66–66. 9 indexed citations
11.
Vernochet, Cécile, Virginie Mariot, Vincent Gache, et al.. (2016). Genetic Evidence That Captured Retroviral Envelope syncytins Contribute to Myoblast Fusion and Muscle Sexual Dimorphism in Mice. PLoS Genetics. 12(9). e1006289–e1006289. 38 indexed citations
12.
Mariot, Virginie, Stéphane Roche, Christophe Hourdé, et al.. (2015). Correlation between low FAT1 expression and early affected muscle in facioscapulohumeral muscular dystrophy. Annals of Neurology. 78(3). 387–400. 33 indexed citations
13.
Mariot, Virginie, et al.. (2014). Nuclear protein spreading: implication for pathophysiology of neuromuscular diseases. Human Molecular Genetics. 23(15). 4125–4133. 20 indexed citations
14.
Humbrecht, Catherine, Katy Billot, Virginie Mariot, et al.. (2013). Epigenetic Control of NF-κB-Dependent FAS Gene Transcription during Progression of Myelodysplastic Syndromes. Molecular Cancer Research. 11(7). 724–735. 15 indexed citations
15.
Mariot, Virginie, Bettina Bessières, Alexandre Vasiljevic, et al.. (2013). DUX4 and DUX4 downstream target genes are expressed in fetal FSHD muscles. Human Molecular Genetics. 23(1). 171–181. 59 indexed citations
16.
Krom, Yvonne D., Julie Dumonceaux, Kamel Mamchaoui, et al.. (2012). Generation of Isogenic D4Z4 Contracted and Noncontracted Immortal Muscle Cell Clones from a Mosaic Patient. American Journal Of Pathology. 181(4). 1387–1401. 66 indexed citations
17.
Maupetit‐Mehouas, Stéphanie, Virginie Mariot, Christelle Reynès, et al.. (2010). Quantification of the methylation at the GNAS locus identifies subtypes of sporadic pseudohypoparathyroidism type Ib. Journal of Medical Genetics. 48(1). 55–63. 45 indexed citations
18.
19.
Mariot, Virginie, Stéphanie Maupetit‐Mehouas, Christiane Sinding, Marie‐Laure Kottler, & Agnès Linglart. (2008). A Maternal Epimutation of GNAS Leads to Albright Osteodystrophy and Parathyroid Hormone Resistance. The Journal of Clinical Endocrinology & Metabolism. 93(3). 661–665. 79 indexed citations
20.
Munier, Sandie, et al.. (2003). In vitro infection of human primary adipose cells with HIV-1. AIDS. 17(17). 2537–2539. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Virginie Carmignac Breakdown of academic impact, for papers by Yuko Nitahara‐Kasahara Breakdown of academic impact, for papers by Lori A. Reed Breakdown of academic impact, for papers by Sergia Bortolanza Breakdown of academic impact, for papers by David R. Deyle Breakdown of academic impact, for papers by Vincent Marion Breakdown of academic impact, for papers by Siamak Agha‐Mohammadi Breakdown of academic impact, for papers by Joel Schneider Breakdown of academic impact, for papers by Bernard Gjata Breakdown of academic impact, for papers by Regan‐Heng Zhang
Rankless by CCL
2026